Amber Prasad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amber Prasad has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Amit Tyagi
Otolaryngology, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND
1 shared publication- Bharathi Mohan
Senior Resident, Department of Gastroenterology, All India Institute of Medical Sciences, Patna, India
1 shared publication Binal Mangroliya
Microbiology, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND
1 shared publication- Manjunath Totaganti
Internal Medicine, All India Institute of Medical Sciences, Rishikesh, IND
1 shared publication - Mukesh Bairwa
Department of Internal Medicine, AIIMS, Rishikesh, Uttarakhand, India
1 shared publication - Prasan Kumar Panda
Department of Internal Medicine, All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
An Uncommon Mould in an Uncommon Place: A Case of Scopulariopsis brevicaulis Keratitis From the Northern Himalayas, India
Scopulariopsis brevicaulis is an uncommon cause of fungal keratitis, usually occurring after ocular trauma, and is associated with therapeutic difficulties because of its limited susceptibility to antifungal agents. We report the case of a 48-year-old man who presented with pain, redness, and watering of the left eye for one month following injury by iron foreign body particles during welding. Ocular examination revealed a corneal ulcer with hypopyon and markedly reduced visual acuity (2/60). Initial microscopic evaluation was negative for fungal elements; however, fungal culture after extended incubation yielded growth of S. brevicaulis, identified based on colony characteristics and microscopic morphology. Imaging further demonstrated left-sided dacryoadenitis. The patient was treated conservatively with intensive topical natamycin and voriconazole, along with systemic ketoconazole and supportive topical antibiotics. This approach led to clinical improvement, although some degree of visual impairment persisted. This case highlights the importance of maintaining a high index of suspicion, allowing prolonged incubation of fungal cultures, and initiating timely targeted antifungal therapy in rare mould keratitis to achieve favorable outcomes and potentially avoid surgical intervention.
- 1 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Open AccessAn Uncommon Mould in an Uncommon Place: A Case of Scopulariopsis brevicaulis Keratitis From the Northern Himalayas, India
Scopulariopsis brevicaulis is an uncommon cause of fungal keratitis, usually occurring after ocular trauma, and is associated with therapeutic difficulties because of its limited susceptibility to antifungal agents. We report the case of a 48-year-old man who presented with pain, redness, and watering of the left eye for one month following injury by iron foreign body particles during welding. Ocular examination revealed a corneal ulcer with hypopyon and markedly reduced visual acuity (2/60). Initial microscopic evaluation was negative for fungal elements; however, fungal culture after extended incubation yielded growth of S. brevicaulis, identified based on colony characteristics and microscopic morphology. Imaging further demonstrated left-sided dacryoadenitis. The patient was treated conservatively with intensive topical natamycin and voriconazole, along with systemic ketoconazole and supportive topical antibiotics. This approach led to clinical improvement, although some degree of visual impairment persisted. This case highlights the importance of maintaining a high index of suspicion, allowing prolonged incubation of fungal cultures, and initiating timely targeted antifungal therapy in rare mould keratitis to achieve favorable outcomes and potentially avoid surgical intervention.
- Open Access
- 4 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25652
Clinical Characteristics of 100 Patients With COVID-19-Associated Mucormycosis From a Tertiary Care Center in North India
Fungal infection in patients with coronavirus disease 2019 (COVID-19) has emerged as a new challenge in healthcare facilities. This study aimed to describe the demographic and clinical characteristics of COVID-19-associated mucormycosis (CAM). This retrospective, single-center case series included patients who were hospitalized and diagnosed with COVID-19 and mucormycosis at the All India Institute of Medical Sciences, Rishikesh (North India) from April 15, 2021, onwards and last followed up on June 30, 2021. Demographic, clinical, laboratory, radiological, microbiological, pathological, and outcome data were then collected and analyzed. Of the 100 consecutive inpatients with CAM, 95 (95%) had diabetes mellitus. At the onset of illness, the most common manifestations were facial swelling (85%), eye swelling (83%), headache (68%), pain around the eyeball (67%), malaise (57%), and fever (50%). The most common organ involved on examination was the nose and paranasal sinus (96%), followed by the orbit (83%), palate (19%), and cranial nerves (7%). Pulmonary involvement was seldom observed (1%). Predominant pathological findings were the presence of aseptate hyphae (75%), necrosis (75%), angioinvasion (36%), and perineural invasion (2.6%). During the last follow-up, 13 patients died, with 11 (84.6%) having severe COVID-19 and two (15.3%) having moderate COVID-19. Steroid use and diabetes mellitus are the significant risk factors of CAM. Patients with CAM usually present with face/eye swelling with radiological involvement of the nose and sinus and may die because of severe COVID-19.
- 4 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25652
Open AccessClinical Characteristics of 100 Patients With COVID-19-Associated Mucormycosis From a Tertiary Care Center in North India
Fungal infection in patients with coronavirus disease 2019 (COVID-19) has emerged as a new challenge in healthcare facilities. This study aimed to describe the demographic and clinical characteristics of COVID-19-associated mucormycosis (CAM). This retrospective, single-center case series included patients who were hospitalized and diagnosed with COVID-19 and mucormycosis at the All India Institute of Medical Sciences, Rishikesh (North India) from April 15, 2021, onwards and last followed up on June 30, 2021. Demographic, clinical, laboratory, radiological, microbiological, pathological, and outcome data were then collected and analyzed. Of the 100 consecutive inpatients with CAM, 95 (95%) had diabetes mellitus. At the onset of illness, the most common manifestations were facial swelling (85%), eye swelling (83%), headache (68%), pain around the eyeball (67%), malaise (57%), and fever (50%). The most common organ involved on examination was the nose and paranasal sinus (96%), followed by the orbit (83%), palate (19%), and cranial nerves (7%). Pulmonary involvement was seldom observed (1%). Predominant pathological findings were the presence of aseptate hyphae (75%), necrosis (75%), angioinvasion (36%), and perineural invasion (2.6%). During the last follow-up, 13 patients died, with 11 (84.6%) having severe COVID-19 and two (15.3%) having moderate COVID-19. Steroid use and diabetes mellitus are the significant risk factors of CAM. Patients with CAM usually present with face/eye swelling with radiological involvement of the nose and sinus and may die because of severe COVID-19.